Acta Scientific Women's Health (ASWH)(ISSN: 2582-3205)

Short Communication Volume 2 Issue 2

Premenstrual Syndrome (PMS)/Premenstrual Dysphoric Disorder (PMDD): Let’s Talk About

Binu Shrestha*

Formerly Trinity School of Medicine, St. Vincent and The Grenadines

*Corresponding Author: Binu Shrestha, Formerly Trinity School of Medicine, St. Vincent and The Grenadines.

Received: December 02, 2019; Published: January 11, 2020


  Many women in their reproductive age experience transient physical and emotional changes around the time of their menses. For the majority of women, these symptoms are mild and tolerable. However, for a certain group of women, these symptoms can be disabling and may cause significant disruption in their lives. Around 3–9% of women having severe premenstrual syndrome seek medical attention. The general pattern of physical, emotional, and behavioral symptoms occurring 1-2 weeks before menses and remitting with the onset of menses simply called premenstrual syndrome (PMS). Some degree of PMS is experienced by almost 75% of women in their reproductive years [1,2]. PMS was first by Frank in 1931, but according to the modern concept it is named as premenstrual dysphoric disorders (PMDD) which is a severe form of premenstrual syndrome.



  1. Johnson SR. “The epidemiology and social impact of premenstrual symptoms”. Clinical Obstetrics and Gynecology 30 (1987): 367-376.
  2. Steiner M. “Premenstrual syndromes”. Annual Review of Medicine 48 (1997): 447-455. 
  3. Pearlstein T and Steiner M. “Premenstrual dysphoric disorder: Burden of illness and treatment update”. Journal of Psychiatry and Neuroscience 33 (2008): 291-301.
  4. World Health Organization (WHO). International statistical classification of disease and health related problems. 10th revision (ICD -10). Geneva: WHO (1992).
  5. Tenkir A., et al. “Premenstrual syndrome: Prevalence and effect on academic and social performances of students in Jimma University, Ethiopia”. Journal of Health Development 17 (2002): 181-188.
  6. Schiola A., et al. “The Burden of Moderate/Severe Premenstrual Syndrome and Premenstrual Dysphoric Disorder in a Cohort of Latin American Women”. Value Health 14 (2011): S93-S95.
  7. Matsumoto T., et al. “Altered autonomic nervous system activity as a potential etiological factor of premenstrual syndrome and premenstrual dysphoric disorder”. Biopsychic Medicine 1 (2007): 24.
  8. Yang M., et al. “Burden of Premenstrual Dysphoric Disorder on Health Related Quality of Life”. Journal of Women's Health 17.1 (2008): 113-122.
  9. Steiner M., et al. “The premenstrual symptoms screening tool (PSST) for clinicians”. Archives of Women's Mental Health 6 (2003): 203-209.
  10. Borenstein JE., et al. “Health and economic impact of the premenstrual syndrome”. Journal of Reproductive Medicine 48 (2003): 515-524.
  11. American College of Obstetricians and Gynecologists. “Clinical Management Guidelines for Obstetrician-gynecologists: Premenstrual syndrome”. ACOG Practice Bulletin 15 (2000): 1-9.


Citation: Binu Shrestha. “Premenstrual Syndrome (PMS)/Premenstrual Dysphoric Disorder (PMDD): Let’s Talk About”. Acta Scientific Women's Health 2.2 (2020): 42-43.


Acceptance rate35%
Acceptance to publication20-30 days

Indexed In

News and Events

  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is June 25, 2024.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of "Best Article of the Issue"
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.

Contact US